HemeOncBuddy
Main
Trials
Notes
Algorithms
Flashcards
Qbank
Conferences
Stats
About
Study aid only.
Verify against current guidelines, primary literature, staging manuals, and prescribing information before clinical use.
← All algorithms
·
Related notes →
Recurrent / Metastatic Salivary Gland Tumors — Systemic Therapy
Recurrent / metastatic
salivary gland tumor
Biomarker-directed
No actionable target
Adenoid cystic (ACC)
AR+
Androgen deprivation
abiraterone / bicalutamide / LHRH ↗
HER2+
HER2-targeted (T-DM1 / T-DXd)
trastuzumab ± pertuzumab ↗
NTRK
TRK inhibitor
laro / entrectinib ↗
RET
Selpercatinib
LIBRETTO-001 ↗
BRAF
Dabrafenib + trametinib
ROAR ↗
Chemo
Carboplatin / paclitaxel
or cisplatin/vinorelbine, CAP
TKI
Lenvatinib
VEGFR-directed ↗
TKI
Sorafenib
alternative ↗